
Joseph P Neglia MD
Professor, Pediatrics, University of Minnesota Medical School
Join to View Full Profile
2450 Riverside AveJourney ClinicMinneapolis, MN 55454
Phone+1 612-624-3113
Fax+1 612-626-6601
Dr. Neglia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1984 - 1987
- Baylor College of Medicine (Houston)Residency, Pediatrics, 1981 - 1984
- Loma Linda University School of MedicineClass of 1981
Certifications & Licensure
- MN State Medical License 1986 - 2025
- SD State Medical License Active through 2025
- ND State Medical License 1998 - 2002
- TX State Medical License 1982 - 1987
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia Start of enrollment: 2004 Mar 01
- Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia Start of enrollment: 2004 May 01
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.Seth J Rotz, Kayla Stratton, Wendy M Leisenring, Susan A Smith, Rebecca M Howell
Journal of Clinical Oncology. 2025-04-01 - Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancer.Cindy Im, Hasibul Hasan, Emily Stene, Sarah Monick, Ryan K Rader
Nature Communications. 2025-03-31 - DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children's Oncology Group and the Childh...Xuexia Wang, Purnima Singh, Romina B Cejas, Liting Zhou, Noha Sharafeldin
Circulation. Genomic and Precision Medicine. 2025-03-28
Journal Articles
- Risk of Solid Subsequent Malignant Neoplasms After Childhood Hodgkin Lymphoma–Identification of High‐Risk Populations to Guide Surveillance: A Report from the Late Eff...David Tishler, Anna T Meadows, Joseph P Neglia, Kimberley Dilley, Rajaram Nagarajan, Laura T Martin, Lisa R Diller, Cancer
Press Mentions
- M Health Fairview University of Minnesota Masonic Children’s Hospital Is Twin Cities’ Top-Ranked Children’s Hospital, According to U.S. News & World ReportJune 15th, 2021
- M Health Fairview University of Minnesota Masonic Children’s HospitalJune 16th, 2020
- University of Minnesota Masonic Children's Hospital Named One of the Nation's Best HospitalsJune 19th, 2019
- Join now to see all
Grant Support
- Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT ConsortiumVANDERBILT UNIVERSITY MEDICAL CENTER2018–2025
- Bedside To Bench And Back Again: Training Pediatricians In Translational ResearchEunice Kennedy Shriver National Institute Of Child Health &Human Development2011–2012
- Childrens Cancer GroupNational Cancer Institute1999–2002
- Children'S Cancer GroupNational Cancer Institute1997–1998
- Second Malignant Neoplasms Following Childhood LeukemiaNational Cancer Institute1987–1991
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: